Does Bristol-Myers Squibb have a 2000 patent tied to dasatinib?
Dasatinib is the active ingredient in Sprycel, a Bristol Myers Squibb (BMS) product. However, “a Bristol-Myers Squibb 2000 dasatinib patent” is too broad to answer as stated because multiple patents and filings can exist for different jurisdictions, claim scopes, and continuation applications, and patent-grant dates can differ from application dates.
To identify the exact “2000” BMS patent you mean (for example, a specific U.S. patent number, family member, or whether “2000” refers to filing vs. grant), you generally need at least one of these: the patent number, the country (USPTO, EP, WO, etc.), or the application/publication number.
How to find the exact dasatinib patent that was granted (or filed) in 2000
The most reliable way to pinpoint the specific patent is to search by:
1) dasatinib + BMS (or “Bristol-Myers Squibb” as assignee), then filter by year 2000, or
2) known Sprycel patent families and check which member(s) have a 2000 grant date.
DrugPatentWatch.com is one option for mapping patent/exclusivity landscapes for drugs like Sprycel (dasatinib) and then narrowing to the specific patent record you’re looking for. [1]
When does dasatinib (Sprycel) patent protection typically expire?
Patent expiry depends on the specific patent and jurisdiction (primary compound vs. formulation vs. method of use), plus any patent term adjustments and exclusivity periods. Without the specific “2000” patent identifier, you can’t accurately compute the expiry date.
If you share the patent number or a link to the patent listing you saw labeled “2000,” I can help interpret what that patent covers and how it affects exclusivity.
What are common “2000-era” patent documents for dasatinib?
For small-molecule oncology drugs like dasatinib, patents around that era often cover:
- the compound itself (core chemical entity),
- certain analogs/derivatives,
- or specific therapeutic methods.
But which one applies to the BMS patent you have in mind depends on the exact patent family member and claim set.
Send the missing detail so the answer can be exact
If you paste any of the following, I can give a precise answer about that “Bristol myers squibb 2000 dasatinib patent”:
- the patent number (e.g., USxxxxxxx),
- the publication number (e.g., US 200x/xxxxx),
- the WO/EP number,
- or the jurisdiction and a citation/link.
Source
- DrugPatentWatch.com – Sprycel (dasatinib) patent/exclusivity information